Astemizole-Associated Urinary Retention

1. Douglas WW . Histamine, 5H tryptamine (serotonin) and their antagonists. In: Gillman AG Goodman CF Rail TW , eds. The pharmacologic basis of therapeutics. New York: McMillan Publishing, 1985; 605–38.

2. McEvoy GK , ed. American Hospital Formulary Service—Drug Information, 1990. Bethesda: American Society of Hospital Pharmacists, 1990;2–5.

3. Norman PS . Modulation of the mast cell and inhibition of its mediators. J Allergy Clin Immunol 1985;76:366–8.

4. Laduron PM Janssen PFM Gommeren W In vitro and in vivo binding characteristics of a new long-acting histamine H-1 antagonist, astemizole. Mol Pharmacol 1982;21:294–300.

5. Vanden Bussche G Emanuel MB Rombaut N . Clinical profile of astemizole: a survey of 50 double-blind trials. Ann Allergy 1987;58:184–8.

6. Vanden Bussche G Rombaut N Schuermans V Clinical activity of astemizole: a review of world-wide data. In: Pharmaceutica Janssen , ed. Astemizole: a new, non-sedative, long-acting H-l antagonist. Oxford: Medicine Publishing Foundation, 1983; 101–12.